Tags: US | Multiple | Sclerosis | Drug | FDA

FDA Clears Acorda Drug for Multiple Sclerosis

Friday, 22 Jan 2010 04:08 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Federal health regulators have approved an Acorda Therapeutics drug to improve walking in patients with multiple sclerosis, an often disabling disease that affects the nervous system.

The Food and Drug Administration says Ampyra is the first drug approved to help multiple sclerosis patients walk. The agency says 400,000 patients in the U.S. have the disease.

Multiple sclerosis affects the brain and nervous system, causing loss of balance, muscle spasms and other movement problems.

Acorda, based in Hawthorne, N.Y., conducted two trials tracking patients' ability to complete a walking exercise. Both studies showed significant improvement in patients' walking speed.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
You May Also Like
Around the Web

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved